SUN NELSON (Chief Financial Officer) sold 68.4% of their position (76.75K shares) of AARDVARK THERAPEUTICS, INC. on the open market
Open‑market sale worth $395.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/12/2026ACC: 0001193125-26-389564
Officer· Chief Financial Officer
Since Feb 2026
-76.75K
Net shares
Net seller
$395.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
76.75K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
−14.75K
Price / share
$5.00
Trade value
$73.78K
% of position
13.1%
9/10/2026
112.23K→97.47K
Common Stock, par value $0.00001 per share
Direct
Shares
−62K
Price / share
$5.18
Trade value
$321.18K
% of position
63.6%
9/11/2026
97.47K→35.48K
Total
Net shares
−76.75K
Net value
-$394.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 9/10/2026 | S · Sale | −14.75K | $5.00 | $73.78K | 13.1% | 112.23K | 97.47K |
| Common Stock, par value $0.00001 per share Direct | 9/11/2026 | S · Sale | −62K | $5.18 | $321.18K | 63.6% | 97.47K | 35.48K |
| Total | −76.75K | -$394.96K | ||||||
Derivative Transactions0
No derivative transactions reported